Beta Bionics, Inc. Operating Expenses
Beta Bionics, Inc. (BBNX) reported Operating Expenses of $44.48 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-07-29
- Beta Bionics, Inc. operating expenses for the quarter ending 2026-06-30 was $44.48M, a 37.39% increase year-over-year.
- Beta Bionics, Inc. operating expenses for the quarter ending 2026-03-31 was $40.71M, a 47.42% increase year-over-year.
- Beta Bionics, Inc. operating expenses for the quarter ending 2025-12-31 was $35.07M, a 41.83% increase year-over-year.
- Beta Bionics, Inc. operating expenses for the quarter ending 2025-09-30 was $32.16M, a 61.69% increase year-over-year.
- Beta Bionics, Inc. operating expenses for fiscal 2025 was $127.22M, a 56.79% increase from fiscal 2024.
- Beta Bionics, Inc. operating expenses for fiscal 2024 was $81.14M, a 92.46% increase from fiscal 2023.
- Beta Bionics, Inc. operating expenses for fiscal 2023 was $42.16M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $44.48M 10-Q · filed 2026-07-29 | $85.19M 10-Q · filed 2026-07-29 | $120.26M derived: sum of 3 quarters · filed 2026-07-29 | $152.42M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $40.71M 10-Q · filed 2026-04-21 | $75.78M derived: sum of 2 quarters · filed 2026-04-21 | $107.94M derived: sum of 3 quarters · filed 2026-04-21 | $140.31M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $35.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $67.23M derived: sum of 2 quarters · filed 2026-02-24 | $99.61M derived: sum of 3 quarters · filed 2026-07-29 | $127.22M 10-K · filed 2026-02-24 |
| 2025-09-30 | $32.16M 10-Q · filed 2025-10-28 | $64.54M derived: sum of 2 quarters · filed 2026-07-29 | $92.15M 10-Q · filed 2025-10-28 | $116.88M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $32.38M 10-Q · filed 2026-07-29 | $59.99M 10-Q · filed 2026-07-29 | $84.71M derived: sum of 3 quarters · filed 2026-07-29 | $104.61M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $27.61M 10-Q · filed 2026-04-21 | $52.34M derived: sum of 2 quarters · filed 2026-04-21 | $72.23M derived: sum of 3 quarters · filed 2026-04-21 | $92.10M derived: sum of 4 quarters · filed 2026-04-21 |
| 2024-12-31 | $24.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $44.62M derived: sum of 2 quarters · filed 2026-02-24 | $64.48M derived: sum of 3 quarters · filed 2026-02-24 | $81.14M 10-K · filed 2026-02-24 |
| 2024-09-30 | $19.89M 10-Q · filed 2025-10-28 | $39.76M derived: sum of 2 quarters · filed 2025-10-28 | $56.41M 10-Q · filed 2025-10-28 | |
| 2024-06-30 | $19.87M 10-Q · filed 2025-07-29 | $36.52M 10-Q · filed 2025-07-29 | ||
| 2024-03-31 | $16.65M 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $42.16M 10-K/A · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |